Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — September 2017

Planlagt Fastgjort Låst Flyttet Genmab
1.8k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • J Offline
    J Offline
    jkj
    wrote on sidst redigeret af
    #287

    Så fik de hævet gældsloftet, så er a/b nok tilbage på købssiden imorgen

    1 Reply Last reply
    0
    • M Offline
      M Offline
      Mattiw
      wrote on sidst redigeret af
      #288

      Access to this page has been denied

      px-captcha

      favicon

      (seekingalpha.com)

      1 Reply Last reply
      0
      • M Offline
        M Offline
        Mattiw
        wrote on sidst redigeret af
        #289

        Verastem (NASDAQ:VSTM) is up 30% premarket on average volume in response to its announcement of positive results from a Phase 3 clinical trial, DUO, assessing duvelisib compared to ofatumumab (Novartis' ARZERRA) in patients with relapsed/refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #290

          Darzalex for lung cancer https://m.indiamart.com/proddetail.php?i=14901049948 ???

          1 Reply Last reply
          0
          • P Offline
            P Offline
            pauly
            wrote on sidst redigeret af
            #291

            Lungekræft? Den var ny, men da det er Indien kan det sikkert være fake medicin

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #292

              Cant remember what Novartis paid for ofatumumab rights, but maybe they should have bought Verastem 😞

              1 Reply Last reply
              0
              • J Offline
                J Offline
                Jedi
                wrote on sidst redigeret af
                #293

                Duvelisib, the Verastem drug, is a PI3K kinase inhibitor https://en.wikipedia.org/wiki/Duvelisib that works in a different way than the CD20 antibody ofatumumab. Novartis likely bought the Arzerra rights due to the potential in MS and not so much in CLL and other cancers where Ibrutinib and other kinase inhibitors see much
                success

                1 Reply Last reply
                0
                • MadsSkjernM Offline
                  MadsSkjernM Offline
                  MadsSkjern
                  wrote on sidst redigeret af
                  #294

                  Godmorgen. Partial clinical hold på opdivo studier i mm. Går mest ud over elotuzomab, men også dara fase 1 pauseres. Dog fortsætter pt med klinisk respons. https://investors.bms.com/iframes/press-releases/press-release-details/2017/Bristol-Myers-Squibb-Provides-an-Update-on-Three-Opdivo-based-Combination-Clinical-Studies-in-Multiple-Myeloma-/default.aspx

                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    jkj
                    wrote on sidst redigeret af
                    #295

                    Godmorgen

                    1 Reply Last reply
                    0
                    • B Offline
                      B Offline
                      bibob
                      wrote on sidst redigeret af
                      #296

                      God morgen. 🙂

                      1 Reply Last reply
                      0
                      • B Offline
                        B Offline
                        bibob
                        wrote on sidst redigeret af
                        #297

                        Det kan ikke undre at der bliver sat pause på nogle forsøg da der er mange forskellige kombier igang på tværs af Big pharma. Ikke alt er jo lige velegnet at kombinere.

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #298

                          God morgen. 🙂

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #299

                            FDA handler hurtigt må man sige. Bliver interessant at se om det først og fremmest er PD-1-blokkerne de er efter og om atezolizumab og Durvalumab går fri.

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #300

                              Kan huske Jan i begyndelsen af æraen med daratumumab kombi-samarbejde med checkpointinhibitorer sagde, at han så de bedste muligheder med den ene af slagsen PD1 eller PD-L1

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                Sukkeralf
                                wrote on sidst redigeret af
                                #301

                                Fandt dog aldrig ud af hvad han var mest tilhænger af - og hvorfor

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #302

                                  Oplagt spm til næste Q&A

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    bibob
                                    wrote on sidst redigeret af
                                    #303

                                    Hvilke forsøg kører der med PD1/PD-L1 og Dara , og i hvilke faser ?

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #304

                                      Søg på ct dara-kombier med atezolizumab, durvalumab, nivolumab og pembrolizumab.

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #305

                                        Der kører en del både i og uden for MM

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #306

                                          Bulder har vist spurgt tidligere, men måske tiden er en anden nu

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger